Centene Corp Files 8-K for Regulation FD Disclosure

Ticker: CNC · Form: 8-K · Filed: 2024-09-10T00:00:00.000Z

Sentiment: neutral

Topics: filing, regulation-fd

Related Tickers: CNC

TL;DR

Centene filed an 8-K for Reg FD. No specifics yet.

AI Summary

Centene Corporation filed an 8-K on September 10, 2024, reporting an event that occurred on September 9, 2024. The filing is categorized under Regulation FD Disclosure, indicating it pertains to material information that could affect investor decisions. No specific financial transactions or operational updates are detailed in the provided excerpt.

Why It Matters

This filing signals Centene Corporation is disclosing material information to the public, which could impact investor understanding of the company's current status.

Risk Assessment

Risk Level: low — The provided excerpt is a standard SEC filing notification and does not contain specific financial or operational details that would indicate immediate risk.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Centene Corporation?

The primary purpose of this 8-K filing is for Regulation FD Disclosure, indicating the company is reporting material information.

On what date was this 8-K report filed?

The 8-K report was filed on September 10, 2024.

What is the earliest event date reported in this filing?

The earliest event date reported in this filing is September 9, 2024.

In which state is Centene Corporation incorporated?

Centene Corporation is incorporated in Delaware.

What is the address of Centene Corporation's principal executive offices?

The address of Centene Corporation's principal executive offices is 7700 Forsyth Boulevard, St. Louis, Missouri 63105.

From the Filing

0001071739-24-000170.txt : 20240910 0001071739-24-000170.hdr.sgml : 20240910 20240909205244 ACCESSION NUMBER: 0001071739-24-000170 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240910 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20240910 DATE AS OF CHANGE: 20240909 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 041406317 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 241288583 BUSINESS ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 8-K 1 cnc-20240910.htm 8-K cnc-20240910 0001071739 false 0001071739 2024-09-10 2024-09-10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 10, 2024 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 7700 Forsyth Boulevard, St. Louis, Missouri 63105 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: ( 314 ) 725-4477 (Former Name or Former Address, if Changed Since Last Report): N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, $0.001 Par Value CNC New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company  ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ ITEM 7.01 REGULATION FD DISCLOSURE On September 10, 2024, members of Centene Corporation’s (the "Company") senior management team will meet with investors. Consistent with the Company’s guidance previously provided on September 4, 2024, the senior management team plans to: • reaffirm the Company’s 2024 full year adjusted diluted earnings per share (EPS) guidance of greater than $6.80; • reiterate the shift of 20 to 30 cents of adjusted diluted EPS from Q3 to Q4. Therefore, the Company projects Q3 adjusted diluted EPS of between $1.31 to $1.41, with the remainder of the 2024 full year adjusted diluted EPS to be realized in Q4; and • reiterate that, with regard to Medicare Advantage, the Company continues to be encouraged by the progress it has made in the improvement of its stars program performance. Non-GAAP Financial Pre

View on Read The Filing